These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1261 related articles for article (PubMed ID: 11687035)

  • 21. Azapirones for generalized anxiety disorder.
    Chessick CA; Allen MH; Thase M; Batista Miralha da Cunha AB; Kapczinski FF; de Lima MS; dos Santos Souza JJ
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006115. PubMed ID: 16856115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials.
    Geddes JR; Burgess S; Hawton K; Jamison K; Goodwin GM
    Am J Psychiatry; 2004 Feb; 161(2):217-22. PubMed ID: 14754766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis.
    Severus E; Taylor MJ; Sauer C; Pfennig A; Ritter P; Bauer M; Geddes JR
    Int J Bipolar Disord; 2014; 2():15. PubMed ID: 25530932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lithium and suicide prevention in mood disorders and in the general population: A systematic review.
    Del Matto L; Muscas M; Murru A; Verdolini N; Anmella G; Fico G; Corponi F; Carvalho AF; Samalin L; Carpiniello B; Fagiolini A; Vieta E; Pacchiarotti I
    Neurosci Biobehav Rev; 2020 Sep; 116():142-153. PubMed ID: 32561344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.
    Smith LA; Cornelius V; Warnock A; Bell A; Young AH
    Bipolar Disord; 2007 Jun; 9(4):394-412. PubMed ID: 17547586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maintenance therapies in bipolar disorder: focus on randomized controlled trials.
    Muzina DJ; Calabrese JR
    Aust N Z J Psychiatry; 2005 Aug; 39(8):652-61. PubMed ID: 16050919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
    Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M
    Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lithium treatment and suicide risk in major affective disorders: update and new findings.
    Baldessarini RJ; Tondo L; Hennen J
    J Clin Psychiatry; 2003; 64 Suppl 5():44-52. PubMed ID: 12720484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis.
    Davis JM; Janicak PG; Hogan DM
    Acta Psychiatr Scand; 1999 Dec; 100(6):406-17. PubMed ID: 10626918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating the suicidal patient with bipolar disorder. Reducing suicide risk with lithium.
    Baldessarini RJ; Tondo L; Hennen J
    Ann N Y Acad Sci; 2001 Apr; 932():24-38; discussion 39-43. PubMed ID: 11411189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interventions for helping people recognise early signs of recurrence in bipolar disorder.
    Morriss RK; Faizal MA; Jones AP; Williamson PR; Bolton C; McCarthy JP
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD004854. PubMed ID: 17253526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies.
    Calabrese JR; Goldberg JF; Ketter TA; Suppes T; Frye M; White R; DeVeaugh-Geiss A; Thompson TR
    Biol Psychiatry; 2006 Jun; 59(11):1061-4. PubMed ID: 16769295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Non-conventional pharmacological agents for the treatment of bipolar disorder: Α systematic review of the evidence].
    Fountoulakis KN; Balaris D; Nikolaou V; Νimatoudis J
    Psychiatriki; 2016; 27(4):253-263. PubMed ID: 28114089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omega-3 fatty acids for bipolar disorder.
    Montgomery P; Richardson AJ
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005169. PubMed ID: 18425912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy for posttraumatic stress disorder.
    Stein DJ; Zungu-Dirwayi N; van Der Linden GJ ; Seedat S
    Cochrane Database Syst Rev; 2000; (4):CD002795. PubMed ID: 11034765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of lithium on suicide and mortality in mood disorders: A systematic review.
    Börjesson J; Gøtzsche PC
    Int J Risk Saf Med; 2019; 30(3):155-166. PubMed ID: 31381531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.